# GlycoVaxyn

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/glycovaxyn

- Industry: Pharmaceuticals
- Headquarters: Schlieren, Switzerland
- Website: www.glycovaxyn.com
- Total disclosed funding: $31M
- Latest round: Series B (Mar 5, 2009)
- Investors on record: 3

## About

GlycoVaxyn is a biotechnology company specializing in the development of innovative vaccine solutions aimed at enhancing immune responses to infectious diseases.GlycoVaxyn focuses on creating advanced vaccine technologies. The company was acquired by GlaxoSmithKline Plc in February 2015 for USD 190.00 mn. Headquartered in Schlieren, Switzerland, GlycoVaxyn has engaged in five significant deals to date.The company offers a range of innovative vaccine products designed to address specific challenges in infectious diseases. Their core offerings focus on advanced technology solutions that enhance immune responses and improve patient outcomes. GlycoVaxyn serves a diverse client base, including healthcare providers and pharmaceutical companies, across various markets such as Europe and North America.The revenue structure of GlycoVaxyn is primarily based on direct sales to healthcare institutions and collaborations with pharmaceutical companies. The transactions often involve agreements for bulk purchases, reflecting a pricing strategy aimed at ensuring competitive access to their vaccine products.GlycoVaxyn plans to utilize the resources from its acquisition to enhance its vaccine development pipeline, with a focus on launching new vaccine candidates targeting emerging infectious diseases in the next few years. The company aims to expand its market presence in Asia and North America by 2025, aligning with growing global health demands. The recent acquisition funding will support ongoing research and development initiatives, facilitating the introduction of innovative vaccine solutions.

## Funding rounds

- Series B, Mar 5, 2009, $21M — Index Ventures, Sofinnova Partners, Andera Partners
- Series A, Jul 16, 2007, $9.4M — Index Ventures, Sofinnova Partners
- Seed, Jul 1, 2006, $0.8M — Index Ventures, Sofinnova Partners

## Investors

- Index Ventures (https://capitalatlas.ai/funds/index-ventures) — Seed, Series A, Series B
- Sofinnova Partners (https://capitalatlas.ai/funds/sofinnova-partners) — Seed, Series A, Series B
- Andera Partners (https://capitalatlas.ai/funds/andera-partners) — Series B